Metraipolis › archive › dc_d02f87a20f05
Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42540262
- DOI
- 10.1021/acsomega.6c03522
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:28:13.576Z
- SHA-256 of the archived text
ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72- Stable URL of this page
https://metraipolis.com/documento/dc_d02f87a20f05
How to cite
Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262 — Europe PMC (en), https://europepmc.org/article/MED/42540262 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d02f87a20f05 (Metraipolis archive dc_d02f87a20f05, sha256 ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72)
BibTeX
@misc{dcd02f87a20f05,
title = {Recent Advances in AS101 and Tellurium-Based Nanoplatforms for Immunomodulation, Cancer Therapy, Antimicrobial Activity, and Toxicological Assessment — Europe PMC PMID:42540262},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42540262},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d02f87a20f05; sha256 ad4ddb4d8817e327aa780494a2c0dabc453c29408dcf4f6309b00169936d8a72},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42540262. Agents can read the archived copy with the MCP tool read_document.